Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,702.00
Ask: 1,703.00
Change: -20.00 (-1.16%)
Spread: 1.00 (0.059%)
Open: 1,729.00
High: 1,729.00
Low: 1,699.00
Prev. Close: 1,725.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

19 Nov 2013 07:00

RNS Number : 3395T
Smiths Group PLC
19 November 2013
 

 

News Release

London, 19 November 2013

For immediate release

 

 

SMITHS GROUP PLC INTERIM MANAGEMENT STATEMENT

 

Smiths Group Chairman Donald Brydon will make the following Interim Management Statement at the Company's Annual General Meeting in London today.

 

In the three months to 2 November 2013, overall trading at Smiths Group has been in line with expectations. Revenue and headline operating profit have both grown on an underlying and reported basis. Headline operating profit improvements in Detection, John Crane and Flex-Tek more than offset some weakness in Medical and Interconnect. Expectations for the year remain broadly in line with the outlook given at the full year results, although foreign exchange translation is expected to be a headwind at current rates and sales to government-funded customers remain a risk.

 

John Crane delivered modest headline operating profit growth in the first quarter as a result of productivity gains and favourable mix. Revenue was at a similar level to last year with continued growth in aftermarket revenues offsetting weaker sales to first fit OEM customers, reflecting the phasing of certain projects. The order book is ahead of last year with a positive book-to-bill ratio. As a result, John Crane is expected to grow in line with the outlook given at the full year results in September.

 

Smiths Medical saw underlying revenue decline as improved hardware sales were more than offset by a weakness in demand for single-use consumables. As expected, headline operating profit in the first quarter was held back by the impact of the US medical device tax and continued tough trading in developed markets. The full year performance is expected to be below the prior year for the same reasons.

 

Smiths Detection delivered strong underlying revenue and headline operating profit in the first quarter against a weak comparator period. We continue to pursue operational improvements and manufacturing efficiencies. The order book for the full year remains slightly below the equivalent point last year. As a result, we remain cautious about the revenue outlook, but expect productivity initiatives to benefit margins.

 

Smiths Interconnect experienced declines in underlying revenue and headline operating profit against a strong comparator period. Growth in Power was offset by lower revenues in Microwave and Connectors caused by a slowdown in demand from defence customers and on-going weakness in Europe, despite increased sales in the telecommunications market. Looking to the full year, improved trading in some commercial end markets is likely to offset weaker demand in defence, resulting in relatively modest growth overall, with a bias to the second half.

 

Flex-Tek has made good progress growing underlying revenue through a strong performance in US residential construction. Headline operating profit and margins improved as a result of the higher volumes. Despite a demanding comparator period, the outlook for the full year remains positive driven by the aerospace order book and US housing.

 

At 2 November, net debt was £740m, slightly reduced from the £744m at 31 July 2013.

 

ENDS

This press release contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group. By their nature, these statements involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. The forward-looking statements reflect knowledge and information available at the date of preparation of the press release and the Company undertakes no obligation to update these forward-looking statements. Nothing in this press release should be construed as a profit forecast.

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777

 

Smiths Group

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLLFEDLELTLIV
Date   Source Headline
1st Nov 201910:30 amRNSTotal Voting Rights
11th Oct 20198:00 amRNSAnnual Financial Report
9th Oct 20192:52 pmRNSDirector/PDMR Shareholding
7th Oct 20194:08 pmRNSDirector/PDMR Shareholding
30th Sep 20195:56 pmRNSTotal Voting Rights
20th Sep 20197:00 amRNSSmiths Group plc Annual Results FY2019
2nd Sep 20199:30 amRNSTotal Voting Rights
5th Aug 20193:27 pmRNSDirector/PDMR Shareholding
1st Aug 201910:30 amRNSDirector/PDMR Shareholding
31st Jul 20195:15 pmRNSTotal Voting Rights
30th Jul 20199:01 amRNSAdditional Listing
26th Jul 20192:00 pmRNSHolding(s) in Company
25th Jul 20191:00 pmRNSDirectorate Change
3rd Jul 20197:00 amRNSSmiths Group extends pension de-risking
1st Jul 201910:47 amRNSTotal Voting Rights
7th Jun 20197:00 amRNSAppointment of Smiths Medical CEO
3rd Jun 20199:00 amRNSTotal Voting Rights
10th May 20191:30 pmRNSDirector/PDMR Shareholding
2nd May 20194:20 pmRNSDirector Declaration
1st May 20199:49 amRNSDirector/PDMR Shareholding
1st May 20199:30 amRNSBlock listing Interim Review
1st Apr 20199:00 amRNSTotal Voting Rights
22nd Mar 20197:01 amRNSSmiths plans for separation of Smiths Medical
22nd Mar 20197:00 amRNSHalf-year Report
28th Feb 20195:15 pmRNSTotal Voting Rights
27th Feb 201911:15 amRNSHolding(s) in Company
1st Feb 201910:24 amRNSDirector/PDMR Shareholding
1st Feb 20198:41 amRNSTotal Voting Rights
2nd Jan 201910:30 amRNSTotal Voting Rights
30th Nov 20185:00 pmRNSTotal Voting Rights
28th Nov 20185:00 pmRNSHolding(s) in Company
14th Nov 20181:36 pmRNSResult of AGM
14th Nov 20187:00 amRNSSmiths Group intention to separate Smiths Medical
14th Nov 20187:00 amRNSTrading Statement
1st Nov 20184:15 pmRNSBlock listing Interim Review
1st Nov 201812:00 pmRNSDirector/PDMR Shareholding
1st Nov 201812:00 pmRNSDirector/PDMR Shareholding
31st Oct 20185:15 pmRNSTotal Voting Rights
26th Oct 20187:00 amRNSSmiths - Appointment of Joint Corporate Broker
19th Oct 20188:27 amRNSDirector/PDMR Shareholding
12th Oct 20189:40 amRNSAnnual Financial Report
10th Oct 201810:15 amRNSDirector/PDMR Shareholding
4th Oct 20183:30 pmRNSHolding(s) in Company
4th Oct 20187:00 amRNSAcquisition
1st Oct 20189:30 amRNSTotal Voting Rights
27th Sep 20182:15 pmRNSDirector/PDMR Shareholding
26th Sep 20181:30 pmRNSDirector/PDMR Shareholding
21st Sep 20187:05 amRNSSmiths Group sells Medical water bottling business
21st Sep 20187:00 amRNSFinal Results
13th Sep 201812:45 pmRNSStatement re Smiths Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.